USPTO serial 99369627
RENU
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RENU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua S. Jarvis
Joshua S. Jarvis Foley Hoag LLP155 Seaport BoulevardBoston, MA 02210-2600United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparation containing human biological material, namely, bioactive suspension derived from human amnion and amniotic fluid used in treating degenerative disease of the articulating joints. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2025 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Sep 3, 2025 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Sep 2, 2025 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 2, 2025 | NWAP | NEW APPLICATION ENTERED | — |